Geneos Therapeutics

Niranjan Sardesai spoke at The World Vaccine Congress in Barcelona today on "Targeting Multiple Neoantigens in Personalized Cancer Vaccines." Learn more about our GT-EPIC platform here: https://lnkd.in/eKdQmpHq #HCC #immunooncology #personalizedmedicine #WVC2024

This week we had our 4th Annual Geneos Liver Walk in Philadelphia to raise awareness and fundraise for Liver Cancer. We are pleased to have come in 2nd as a fundraising team for the American Liver Foundation's Virtual Liver Life Walk. Together we can move closer to a world without liver disease. #livercancer #livercancerawareness #HCC #fundraising #giveback

According the American Cancer Society, Liver Cancer incidence rates have more than tripled since 1980, while the death rates have more than doubled during this time. Hepatocellular Carcinoma (HCC) is the most common type of primary Liver Cancer. Geneos is paving the path in advanced HCC with personalized therapeutic cancer vaccines (PTCVs). Learn more about our Phase 1/2 study in advanced HCC here: #HCC #Livercancer #LCAM #thinkliverlife American Liver Foundation

October is Liver Cancer Awareness Month. For the 4th year in a row, Geneos is participating in the American Liver Foundation's virtual Liver Life Walk. Together, we are moving closer to a world without liver disease. Learn more here: https://lnkd.in/etUnBeHr #HCC #livercancer #LCAM #liverhealth #oncology

Niranjan Sardesai will be speaking today at the Fred Hutch Stuart & Molly Sloan Precision Oncology Institute Symposium: Advances in Cancer Vaccines on Personalized DNA Therapeutic Cancer Vaccines: Phase 1/2 trial in advanced hepatocellular cancer. Read more here: https://lnkd.in/eya6wD-3 #cancervaccines #oncology #research #personalizedmedicine #therapeutics #immunotherapy

Our CMO Ildiko Csiki, M.D., Ph.D. will be participating in a panel at the Fierce Biotech Summit today titled "Pioneering Early-Stage Cancer Therapies: Harnessing Therapeutic Cancer Vaccines for Precision Medicine." Learn more here: https://sched.co/1dOrh #cancervaccines #precisionmedicine #oncology #fiercebiotechsummit #researchanddevelopment #immunotherapy

𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞𝐬 𝐅𝐮𝐭𝐮𝐫𝐞: Plymouth Meeting based Geneos Therapeutics is developing DNA-based personalized therapeutic cancer vaccines. Founder and CEO Niranjan Sardesai describes why is believes a personalized approach is important and how Geneos is working on the technology, which is currently in phase 2 in advanced liver cancer. Full video: https://lnkd.in/g-mMAukg BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent

Our CEO Niranjan Sardesai will speak about how Geneos is bringing personalized therapeutics cancer vaccines to the world one patient at a time at Life Sciences Pennsylvania Future on September 18. Register here: https://lnkd.in/gcpxsb_C #geneos #cancervaccines #personalizedmedicine #lifesciencespa #pennsylvania #future

Learn more about our how we are targeting neoantigens to design patient specific vaccines to treat advanced Hepatocellular Carcinoma in our GT-30 study: https://lnkd.in/d3qm987U Genetic Engineering & Biotechnology News #biotechnology #biotechnews #personalizedmedicine #DNAmedicine #DNA

Our VP of R&D, Jian Yan, Ph. D. will be presenting our GT-30 data and serving on a panel at the #IOSummit today in Philadelphia, PA. Learn more here: https://lnkd.in/ei8eSqjV Cambridge Healthtech Institute #immunooncologysummit #cancervaccines #researchdevelopment #oncologyresearch #geneos